-- Andrew Callos, Executive Vice President, Chief Commercial Officer, on May 01, 2026, sold 15,857 shares in Cytokinetics (CYTK) for $1,030,705. Following the Form 4 filing with the SEC, Callos has control over a total of 58,555 common shares of the company, with 58,555 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1061983/000106198326000046/xslF345X05/form4.xml
IAC (IAC) reported a Q1 loss late Monday of $0.94 per diluted share, narrowing from the loss of $2.64 a year earlier.Analysts polled by FactSet expected a loss of $0.37.Revenue in the three months ended March 31 fell to $422.9 million from $481.7 million a year earlier.Analysts surveyed by FactSet expected $520.3 million.IAC shares fell 8.6% in after-hours trading.
Andre Almeida, Chief Broadband, Enterprise & Emerging Business Officer, on May 01, 2026, executed a purchase for 5,097 shares in T-Mobile US (TMUS) for $1,000,016. Following the Form 4 filing with the SEC, Almeida has control over a total of 44,850 common shares of the company, with 44,850 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1283699/000128369926000069/xslF345X05/wk-form4_1777930593.xml